EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Improvement in Quality of Life and Non‐Motor Symptoms Associated With OFF Episodes in People With Parkinson's Disease Treated With Inhaled Levodopa

Diego Santos García iD, María Cerdán Sánchez iD, Rosa Yáñez Baña, Iria Cabo iD, Maria Icíar Cimas Hernando

European Journal of Neurology · 2026

DOI: 10.1111/ene.70731 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Neurology, 2026. Verfasst von Diego Santos García und 4 weiteren Autor:innen. Beteiligte Einrichtung: Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Quality of Life, Levodopa, Antiparkinson Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Esteve Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CVT‐301 (Inbrija) has demonstrated its effectiveness in treating OFF periods in people with Parkinson's disease (PwP). However, its effect on non‐motor symptoms (NMS) and quality of life has not been researched yet. Our aim was to analyze the change observed in health‐related quality of life (HRQoL) and, as a secondary exploratory analysis, NMS associated with OFF episodes in PwP treated with CVT‐301.

Methods

INLEVO‐LIFE PD (an open‐label study of the effect of INhaled LEVOdopa on quality of LIFE and non‐motor symptoms in Parkinson's Disease) is a prospective open‐label study conducted in five centers in Spain. The change from baseline (V0) to the end of the observational period (12 ± 2 weeks) (V12w) in the 39‐item Parkinson's Disease Quality of Life Questionnaire (PDQ‐39) total score was the primary efficacy measure.

Results

Forty PD patients (age 62.3 ± 9.2 years; 55% males) were included between March/2024 and November/2025. At 12 weeks, 34 patients were using CVT‐301 and completed the follow‐up (85%). The PDQ39 total score decreased from 43.6 ± 24.2 at V0 to 31.4 ± 20.6 at V12w ( p < 0.0001). A significant decrease was observed in the mean score of 4 domains of the PDQ39. NMS burden was reduced at v12w from the OFF state to 30, 60, and 90 min after using CVT‐301 ( p < 0.0001). Mean daily OFF time decreased by 1.6 ± 1.9 h ( p < 0.0001). Adverse events related to CVT‐301 were reported in 35% of the patients.

Conclusion

HRQoL and NMS associated with OFF episodes improved in PwP after 12 weeks using CVT‐301.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseQuality of LifeLevodopaAntiparkinson AgentsHumansMaleMiddle AgedFemaleAgedAdministration, InhalationProspective Studies

Stichwörter der Autor:innen

Parkinson's diseaseeffectivenessinhaledlevodopasafety

Substanzen

LevodopaAntiparkinson Agents

Autor:innen und Institutionen

  • Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain.
  • Grupo de Investigación en Enfermedad de Parkinson y Otros Trastornos del Movimiento, INIBIC (Instituto de Investigación Biomédica de A Coruña), A Coruña, Spain.
  • Hospital San Rafael, A Coruña, Spain.
  • Fundación Degen, A Coruña, Spain.
  • Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Complejo Hospitalario de Cartagena, Murcia, Spain.

ORCID-Profile: Diego Santos García, María Cerdán Sánchez, Iria Cabo

Förderung

  • Esteve Pharmaceuticals

Zitieren

APA

Santos García, D., Cerdán Sánchez, M., Yáñez Baña, R., Cabo, I., & Cimas Hernando, M. I. (2026). Improvement in Quality of Life and Non‐Motor Symptoms Associated With OFF Episodes in People With Parkinson's Disease Treated With Inhaled Levodopa. European Journal of Neurology. https://doi.org/10.1111/ene.70731

Vancouver

Santos García D, Cerdán Sánchez M, Yáñez Baña R, Cabo I, Cimas Hernando MI. Improvement in Quality of Life and Non‐Motor Symptoms Associated With OFF Episodes in People With Parkinson's Disease Treated With Inhaled Levodopa. European Journal of Neurology. 2026. doi:10.1111/ene.70731

BibTeX
@article{SantosGarca2026,
  author = {Santos García, Diego and Cerdán Sánchez, María and Yáñez Baña, Rosa and Cabo, Iria and Cimas Hernando, Maria Icíar},
  title = {Improvement in Quality of Life and Non‐Motor Symptoms Associated With OFF Episodes in People With Parkinson's Disease Treated With Inhaled Levodopa},
  journal = {European Journal of Neurology},
  year = {2026},
  doi = {10.1111/ene.70731}
}
Kostenlos starten →